manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced an agreement with PT Etana Biotechnologies Indonesia (Etana) to out-license
Company Codes:HongKong:1801, OTC-PINK:IVBIY Asia MORE ON THIS TOPIC Layoffs The 5 Largest Biopharma Layoffs of 2024 December 19, 2024 · 7 min read · Angela Gabriel China AstraZeneca Names New International Operations Lead Amid Probe...
ARRAffinity __cfduid OptanonConsent Performance Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site All informati...
manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced an agreement with PT Etana Biotechnologies Indonesia (Etana) to out-license